{"id":62664,"date":"2026-02-18T16:06:08","date_gmt":"2026-02-18T15:06:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/meridian-life-science-expands-ambient-stable-ngs-portfolio-with-the-launch-of-a-lyophilized-enzymatic-dna-fragmentation-kit\/"},"modified":"2026-02-18T16:06:08","modified_gmt":"2026-02-18T15:06:08","slug":"meridian-life-science-expands-ambient-stable-ngs-portfolio-with-the-launch-of-a-lyophilized-enzymatic-dna-fragmentation-kit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/meridian-life-science-expands-ambient-stable-ngs-portfolio-with-the-launch-of-a-lyophilized-enzymatic-dna-fragmentation-kit\/","title":{"rendered":"Meridian Life Science Expands Ambient-Stable NGS Portfolio with the Launch of a Lyophilized Enzymatic DNA Fragmentation Kit"},"content":{"rendered":"
\n

\nThe new product reinforces Meridian\u2019s leadership in enzyme stabilization and enables simplified and decentralized Next-Generation-Sequencing sample preparation.<\/p>\n

CINCINNATI–(BUSINESS WIRE)–The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of its Lyophilized NGS Enzymatic DNA Fragmentation Kit. The kit is designed for ambient-temperature (15-25\u2070C) shipping and storage, eliminating the need for cold-chain requirements and helping laboratories simplify their NGS sample preparation workflows.<\/p>\n

\nThe launch of this new kit extends Meridian\u2019s enzyme stabilization strategy beyond PCR and isothermal amplification and into a critical step of NGS sample preparation, strengthening the company\u2019s leading position as a technology partner for assay developers, platform providers and emerging sequencing applications.<\/p>\n

\nRemoving Cold-Chain Constraints in NGS Sample Preparation<\/b><\/p>\n

\nTraditional NGS workflows rely on refrigerated reagents, which increases cost, handling complexity, and the risk of performance variability due to freeze-thaw cycles. This kit overcomes these limitations with a fully lyophilized formulation that remains stable at ambient temperatures and is rehydrated at the point of use, which reduces handling steps and supports consistent performance.<\/p>\n

\nThis kit is the only ambient-stable enzymatic DNA fragmentation solution commercially available and supports streamlined logistics, simplified laboratory operations, and a more robust workflow deployment across a wide range of sequencing environments.<\/p>\n

\nSupporting the Shift Towards Decentralized Sequencing<\/b><\/p>\n

\nAs NGS expands beyond centralized laboratories, toward automated and point-of-need applications, reagent stability and logistics have become critical barriers to adoption. Meridian\u2019s new enzymatic fragmentation kit addresses these challenges and is designed to integrate with Meridian\u2019s lyophilized NGS library preparation chemistries, supporting emerging decentralized sequencing models where portability, automation, and ease of use are essential.<\/p>\n

\nConsistent, Controlled Fragmentation<\/b><\/p>\n

\nFragmentation variability can impact library quality and downstream sequencing performance. Meridian\u2019s enzymatic fragmentation kit enables precise time-controlled fragmentation, allowing users to produce consistent and adjustable fragment sizes without the need for mechanical shearing instruments.<\/p>\n

\nSimple Integration into NGS Workflows<\/b><\/p>\n

\nThe ready-to-rehydrate format supports:<\/p>\n